Walkey Carl

CIK 00018431891 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001843189

Recent Transactions

30 trades

Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2022-08-02+150,000→ 150,000 total
Award
Neurogene Inc.$NGNE
Restricted Stock Units
2022-02-01+55,000→ 55,000 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2021-08-03+100,000→ 100,000 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-06-16$10.19/sh−600→ 1,352,489 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-06-09$10.82/sh−650→ 1,353,089 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-06-08$11.00/sh−600→ 1,353,739 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-06-04$10.00/sh−600→ 1,354,339 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-05-26$10.00/sh−600→ 1,354,939 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-05-19$10.63/sh−600→ 1,355,539 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-05-12$11.09/sh−1,200→ 1,354,762 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-05-05$11.30/sh−1,200→ 1,355,962 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-04-28$12.58/sh−2,400→ 1,357,162 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-04-26$13.00/sh−600→ 1,359,562 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-04-21$11.98/sh−1,800→ 1,360,162 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-04-14$12.22/sh−1,800→ 1,361,962 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-04-07$12.02/sh−1,800→ 1,363,762 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-04-05$13.00/sh−600→ 1,365,562 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-03-31$11.96/sh−1,800→ 1,366,162 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-03-24$11.95/sh−1,800→ 1,367,962 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-03-22$12.00/sh−600→ 1,369,762 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-03-17$11.36/sh−1,200→ 1,370,362 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-03-10$11.97/sh−1,800→ 1,371,562 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-03-03$11.87/sh−1,800→ 1,373,362 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-02-25$13.00/sh−600→ 1,375,162 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-02-24$12.14/sh−1,800→ 1,375,762 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-02-17$12.70/sh−2,400→ 1,377,562 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-02-10$14.20/sh−3,000→ 1,379,962 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-02-05$14.00/sh−600→ 1,382,962 total
Sale
Neurogene Inc.$NGNE
Common Stock
2021-02-03$13.23/sh−2,400→ 1,383,562 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2021-01-30+45,000→ 45,000 total

Companies

Neurogene Inc.
Senior Vice President
$NGNE

Recent Filings

Address

CO NEOLEUKIN THERAPEUTICS, INC. 360-1616 EASTLAKE AVENUE EAST

SEATTLE, WA, 98102

View on SEC.gov